Global research trends and hotspots of rheumatoid arthritis and mitogen-activated protein kinase-a bibliometrics and visualization analysis
Article History
-
Received: ,
Accepted: ,
Abstract
Abstract
Rheumatoid arthritis (RA) is a common autoimmune disease characterized by synovial hyperplasia and bone erosion, which ultimately leads to joint deformity and disability. The mitogen-activated protein kinase (MAPK) signaling pathway is one of the critical pathways in eukaryotic cells involved in regulating cell mitosis, differentiation, and apoptosis, as well as inflammation and stress responses, and is closely related to the development of RA. Intra-articular cytokines in patients with RA can bind to the corresponding receptors and activate intracellular upstream modulators, which activate the MAPK signaling pathway in a tertiary enzyme-linked manner.
This study aimed to explore the research hotspots in the RA and MAPK signaling pathway research and the research focus and intrinsic connections by identifying the number of papers published annually, authors, institutions, keywords, and journals.
Through bibliometric analyses, it was found that the number of publications surged from 2000 to 2023, and the number of publications in 2017 exceeded 100 articles/year for the first time; it was also the year with the most significant number of publications, the most considerable number of publications was from China, with 536 articles, and the second-ranked was from the United States, with 384 articles; and the most significant number of authors was from the University of California, USA, with Firestein, Gary s. professor, with 28 articles; the first institution with the most significant number of articles is univ calif san diego from the U.S.A., with 37 articles; in the keyword analysis, the frequency and centrality of the keywords are Nf kappa b (347, 0.04), Activation (231, 0.06), Activated protein kinase (211, 0.08), Gene expression (169, 0.09), Tumor necrosis factor (146, 0.07),The trend is still increasing, suggesting that many publications exploring this area will continue to be reported in the future.
This study will help scholars better understand the rheumatoid arthritis and mitogen-activated protein kinase of hotspots in this field and may provide some inspiration for research in this area.
Keywords

This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
1 Introduction
Rheumatoid arthritis (RA) is an autoimmune disease with synovial joint inflammation as the primary clinical manifestation, such as joint swelling and pain, morning stiffness, etc. The incidence of the disease in the population of women is more than that of men, and the peak age of 30–50 years is the peak of the incidence of the disease. As the severity of the disease worsens, RA patients may suffer from different degrees of joint deformity, reduced physical function, and eventual disability.1,2 However, the pathogenesis of RA is unclear due to the complexity of its clinical manifestations and the genetic polymorphisms in different individuals.3 The annual prevalence of RA was 0.46 % from 1980 to 2019, causing a severe socio-economic burden.4 The pathology of RA is characterized by persistent synovial tissue inflammation and hyperplasia triggered by infiltration of inflammatory cells, and the abnormally proliferated synovial tissue gradually invades the cartilage tissue, resulting in cartilage invasion.5 The inflammatory cell infiltration, persistent inflammation, and hyperplasia characterize the pathology of RA. The abnormally proliferating synovial tissue gradually invades the cartilage tissue, resulting in cartilage erosion and damage.5,6
Mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine protein kinases in eukaryotic cells, which are involved in the regulation of mitosis, differentiation, proliferation, and apoptosis, as well as inflammation.7 The MAPK signaling pathway is closely related to the development of RA. In recent years, researchers have carried out many studies from the perspectives of pharmacology, immunology, and genetics to explore the possibility of targeting the MAPK signaling pathway to treat RA.8–10
Bibliometrics, as an interdisciplinary research field, aims to use statistical and mathematical methods to quantitatively analyze multi-dimensional information such as the number, distribution, type, author characteristics, publication year, and citation relationship of scientific literature, and then reveal the intrinsic rules of disciplinary development, research hotspots, paths of knowledge evolution, and academic influence and other deep-level information. It is an essential tool for evaluating research output and influence and a powerful assistant for insight into the development trend of disciplines and predicting the future research direction. In the digital era, with the massive growth of scientific research literature, how to efficiently process and analyze this information has become an urgent problem.11–13 CiteSpace, as a powerful literature visualization and analysis software, provides unprecedented convenience for researchers with its Java-based cross-platform features and intuitive graphical interface. By mining the citation relationship among the literature, the software can automatically draw diverse visual charts such as co-citation analysis charts and author cooperation network charts, which not only intuitively display the knowledge structure within the discipline and the cooperation network of the research community but also help researchers to quickly lock the research hotspots, critical literature, and potential research gaps in a certain period. For the specific research fields of RA and MAPK, applying CiteSpace can help researchers grasp the dynamic changes in the field and identify far-reaching research results and urgent research directions to be explored.
Meanwhile, VOSviewer, another popular bibliometric network visualization software, has also won the favor of many researchers with its unique network analysis capability and rich visualization options. It can construct and display various types of network diagrams, such as co-cited networks and collaborative networks. It also allows users to customize the analysis parameters and view layouts according to their research needs, thus providing more flexibility in exploring the complexity and diversity of disciplinary knowledge structures. In studying RA and MAPK, VOSviewer can also play an essential role in helping researchers deeply understand the knowledge flows and interactions among academic communities in the field.14–16
Although bibliometrics has been heavily reported in medicine, very few studies on bibliometrics study RA and MAPK. In this study, we used state-of-the-art bibliometrics to analyze publications on the analysis of RA and MAPK in the WOS core database from 2000 to 2023. To build a knowledge structure and collaborative network for research on RA and MAPK and to promote academic exchange and knowledge sharing. To more effectively identify research frontiers, assess research impact, identify potential research opportunities, and promote educational exchange and collaboration.
2 Data and methods
2.1 Data sources and collection
The study was conducted using the Core Collection database of Web of Science (WoS), an internationally recognized database for scientific research, and the data retrieval and processing was done by a single researcher in one day to minimize errors and confounding factors in the data. The database was searched from January 1, 2000 to December 31, 2023 with the search terms' TS=(“rheumatoid arthritis” OR “rheumatoid arthritis”) AND (“mitogen-activated protein kinases” OR “mitogen-activated protein kinase”); select ‘Article’ and ‘Review’ for the document type. ‘Article’ and “Review” were chosen as literature types, and patents, conference abstracts, books, irrelevant literature, non-English literature, etc., were excluded,as shown in Fig. 1.

2.2 Bibliometric analysis
The parameter configurations for CiteSpace were established as follows: The temporal scope spanned from January 2000 to December 2023, segmented into 1-year time slices. Node types encompassed keywords and subject categories, with a selection criterion of retaining the top 25 items per slice. Network optimization employed the Pathfinder algorithm to eliminate redundant connections, supplemented by pruning sliced networks and merged networks. Visualization parameters incorporated a timezone view to dynamically illustrate research evolution, keyword cluster labeling via the log-likelihood ratio (LLR) algorithm, and burst detection with default sensitivity to identify emerging hotspots. Data normalization utilized cosine similarity to quantify association strength, while other parameters adhered to default software configurations.
For VOSviewer, visual analyses were conducted on authors, countries/regions, institutions, and highly cited literature, with minimum publication thresholds set to 5 for countries/regions, 8 for institutions, and 5 for authors. In the visualization interface, keyword labels were proportionally scaled based on weight, with connections displayed only for terms exhibiting a frequency ≥5 and association strength >0.3. Core clusters were accentuated through a hybrid density-cluster view and spectral color mapping. During data preprocessing, manual synonym consolidation (e.g., “rheumatoid arthritis”) was performed, and non-specific terms were excluded. Parameters were optimized through iterative pre-experiments to ensure equilibrium between network complexity and interpretability, with critical configurations annotated in figures to ensure reproducibility.
2.3 Data analysis and visualization
VOS viewer 1.6.18, R Studio bibliometrics, and CiteSpace 6.2.R6 software were used for data analysis and visualization, CiteSpace software was used for the visual analysis of authors, countries, institutions, highly cited literature, etc., and VOS viewer was also used for the authors, countries, institutions, highly cited literature, Institutions, Highly Cited Literature, etc. bibliometrics was used for partial tabulation and mapping of authors, countries, journals, keywords, etc.
3 Results
3.1 Literature measurement analysis
A total of 1565 publications were included by searching and downloading the WOS core database publications, of which 1338 were Articles and 227 were Reviews. The publications were analyzed bibliometrically. The trend of publications about RA and MAPK studies is shown in Fig. 2. The analysis of the total publication trend shows that, overall, there is a general upward trend in the number of publications in the field from 2010 to 2023. 2017 was the first year in which the number of publications exceeded 100 publications/year; it was also the most significant year in the number of publications. Overall, RA and MAPK research is in an increasing trend, indicating that scholars' attention to the field is continuous; in 2013–2023, the average number of publications was 81.55 per year, while in 2000–2012, the average number of publications is 51.39 per year, indicating that the number of publications is in an increasing trend in the past 10 years again, and it also shows that RA and MAPK research is a research focus of RA, and a large number of studies are still reported in the late stage.

3.2 Analysis of country cooperation contributions
By analyzing the publications in the WOS core database, a total of 287 countries are included, and the visual analysis of the countries is carried out through the cite space software. The country cooperation map can be seen in Figs. 3 and 4. The most significant number of publications is China, with 536 publications; the second-ranked country is the United States, with 384 publications. The role and value in the field can be reflected by the centrality degree; the top 5 countries in the centrality degree are the USA, China, England, Japan, and India, with the centrality degree of 0.56, 0.2, 0.18, 0.17, 0.14, which shows that the excellent development in the field has played a better role in promoting the development of the field, Fig. 5, Table 1. China, Japan and India is all from Asia, and it is clear from the geographical analysis that Asian countries are more concerned about RA and MAPK research.



| Rank | Country | Frequency | Country | Centrality |
| 1 | CHINA | 536 | USA | 0.56 |
| 2 | USA | 384 | CHINA | 0.2 |
| 3 | SOUTH KOREA | 162 | ENGLAND | 0.18 |
| 4 | JAPAN | 133 | JAPAN | 0.17 |
| 5 | GERMANY | 89 | INDIA | 0.14 |
| 6 | ENGLAND | 83 | GERMANY | 0.13 |
| 7 | INDIA | 56 | ITALY | 0.11 |
| 8 | CANADA | 46 | CANADA | 0.1 |
| 9 | SWITZERLAND | 46 | SWITZERLAND | 0.09 |
| 10 | FRANCE | 42 | BELGIUM | 0.09 |
3.3 Analysis of authors' collaborative contributions
By analyzing the WOS core database publications, a total of 9154 authors were included, and setting the minimum number of author publications to 5, a total of 61 authors met the requirement. Table 2 clearly shows that the author with the largest number of publications is Prof. Firestein, Gary S., from the University of California, USA, with a total number of 28 publications and 2838 citations. Average citations are 101.36. The second largest author is Prof. Boyle, David L. from UCSD School of Medicine. In second place is Professor Boyle, David L of the UCSD School of Medicine, with 12 publications, 498 citations, and an Average citations of 41.5. In third place is Professor Schett, Georgia, of the University of Erlangen-Nuremberg, with 11 publications, 1368 citations, and an Average of 124.36 citations. Among the top three authors, the two with higher publication volumes are both from the UCSD School of Medicine, which has reported many studies on RA and MAPK. The average citations can reflect its better collaborative nature, and the one with a higher publication volume is Liu, Georg from China Pharmaceutical University. The highest number of publications in China are from Prof. Liu Mei from China Pharmaceutical University and Prof Zhang Yi from Chengdu University of Traditional Chinese Medicine. Both authors have 9 publications, but the Average citations are relatively lower than the other authors in the top 10, which may be because the research direction is not the same as that of the majority of the researchers and other factors. Fig. 6,7 shows that Firestein, Gary's professor, and other authors constitute the largest cluster, and other authors also form different clusters according to the unit, research direction, country, and other reasons. Fig. 8 shows that the top 10 authors' publications in the research field, in general, are continuously increasing, basically maintaining every 2–3 years; some of the latest reports in the field, 2004–2012 and 2016–2022, are the top 10 authors with a high density of publications in the two time periods.
| Rank | Author | Record | citations | Average citations |
| 1 | firestein, gary s. | 28 | 2838 | 101.36 |
| 2 | boyle, david l. | 12 | 498 | 41.50 |
| 3 | schett, georg | 11 | 538 | 48.91 |
| 4 | liu, mei | 9 | 139 | 15.44 |
| 5 | yoo, wan-hee | 9 | 428 | 47.56 |
| 6 | zhang, yi | 9 | 138 | 15.33 |
| 7 | gay, steffen | 8 | 553 | 69.13 |
| 8 | hammaker, deepa | 8 | 358 | 44.75 |
| 9 | wei, wei | 8 | 232 | 29.00 |
| 10 | cho, mi-la | 7 | 615 | 87.86 |



3.4 Analysis of institutional cooperation contribution
By analyzing the publications of the WOS core database, a total of 1710 institutions were included, and setting the minimum amount of institutional publications as 8, a total of 62 institutions met the requirements; Table 3 shows that the first institution with the highest amount of publications is univ calif san diego from the United States, with 37 publications, 3063 citations, Average citations is 82.78, and the total link strength is 25. The second institution with the second largest number of articles is the University of shanghai jiao tong univ from China, with 27 articles and 1176 citations, average citations of 43.56, and a total link Strength of 18. The third institution in terms of volume is Anhui Med University from China, with 26 articles, 614 citations, Average citations of 23.62, and a total link strength of 6. The United States accounts for 16.61 % of the top 10 institutions in terms of volume of articles. Among the top 10 institutions, China accounts for 4 institutions, and China accounts for 40.10 % of the top 10 publications.
| Rank | organisations | County | Record | citations | Average citations | total link strength |
| 1 | University of California, San Diego | United States | 37 | 3063 | 82.78 | 25 |
| 2 | Shanghai Jiao Tong University | China | 27 | 1176 | 43.56 | 18 |
| 3 | Anhui Medical University | China | 26 | 614 | 23.62 | 6 |
| 4 | Imperial College London | United Kingdom | 26 | 2237 | 86.04 | 7 |
| 5 | Sun Yat-sen University | China | 22 | 954 | 43.36 | 7 |
| 6 | Catholic University of Korea | South Korea | 20 | 1431 | 71.55 | 18 |
| 7 | Chinese Academy of Sciences | China | 20 | 630 | 31.50 | 25 |
| 8 | Konkuk University | South Korea | 20 | 883 | 44.15 | 17 |
| 9 | Kyung Hee University | South Korea | 20 | 738 | 36.90 | 7 |
| 10 | Medical University of Vienna | Austria | 19 | 1234 | 64.95 | 14 |
Different institutions constitute different partnerships, and among Chinese institutions, Shanghai Jiaotong University, Anhui Medical University, Zhejiang University, Second Military Medical University, Peking University, and the University of Chinese Academy of Sciences constitute good partnerships, Fig. 9. Fig. 10 shows that the top 10 institutions have published in this research area, and in general, the trend shows a continuous increase in the number of publications.


3.5 Analysis of journal
Analyzing the publications in the WOS core database included 474 journals, setting the minimum number of journal publications to 7. A total of 45 journals met the requirements, and the first journal with the highest number of publications was the Journal of Immunology, with 57 publications, 4803 citations, and an Average citation of 84.26. The second organization with the most articles is Arthritis & Rheumatism from China, with 56 articles, 4275 citations, Average citations of 76.34, and a total link strength of 285. The third organization with the highest number of articles is Economics from China. The third largest institution is Anhui Med univ from China, with 49 articles, 3438 citations, Average citations of 70.16, and a total link strength of 137, Table 4.
| Rank | journal | County | Record | citations | Average citations | total link strength |
| 1 | Journal of Immunology | United States | 57 | 4803 | 84.26 | 149 |
| 2 | Arthritis & Rheumatism | United States | 56 | 4275 | 76.34 | 285 |
| 3 | Arthritis Research & Therapy | United Kingdom | 49 | 3438 | 70.16 | 137 |
| 4 | International Immunopharmacology | Netherlands | 42 | 1495 | 35.60 | 100 |
| 5 | Frontiers in Pharmacology | Switzerland | 31 | 418 | 13.48 | 83 |
| 6 | Annals of the Rheumatic Diseases | United Kingdom | 29 | 1973 | 68.03 | 151 |
| 7 | PLOS ONE | United States | 26 | 737 | 28.35 | 33 |
| 8 | Rheumatology | United Kingdom | 26 | 2048 | 78.77 | 137 |
| 9 | Frontiers in Immunology | Switzerland | 25 | 733 | 29.32 | 47 |
| 10 | Journal of Ethnopharmacology | Netherlands | 25 | 634 | 25.36 | 39 |
Journal of Immunology is a leading journal focusing on immunology, covering all aspects of the immune system, including significant research related to rheumatoid arthritis. As a leading immunology journal, its high impact factor means that its study is usually high quality and widely cited. The journal accepts papers across basic immunology, clinical research, and translational research, providing a comprehensive understanding of rheumatoid arthritis, including immune mechanisms, pathophysiology, and potential therapeutic strategies.
The journal frequently publishes new findings on rheumatoid arthritis, including research on immunotherapy, targeted biologics, and individualized medicine. Arthritis & Rheumatism and Arthritis Research & Therapy are specialist journals in rheumatoid arthritis research with high impact and wide academic recognition. Research on rheumatoid arthritis and other rheumatic diseases deepens the understanding of inflammation and autoimmune mechanisms. Figs. 11 and 12 show a good cooperation relationship, and the Journal of Ethnopharmacology, International Immunopharmacology, and Frontiers in Pharmacology are all journals that have been more active in recent years and years. The double overlay analysis of journals shows that Fig. 13 shows the double map overlap of the journals that published papers in the field. The left side represents cited journals, and the right represents citing journals. Colored line paths indicate citation relationships. Analysis of the results shows that the research focused on journals in medicine, clinical medicine, and molecular biology, and the cited journals were mainly from exercise, sports medicine, nursing, health, and rehabilitation. This interdisciplinary networking and collaboration positively reflects current trends and hotspots in multiple fields.



3.6 Analysis of subject categories
Thematic clustering analysis provides valuable insights into the distribution patterns of scholarly literature across specific research domains, while simultaneously revealing the relative academic influence among interdisciplinary fields. This methodological approach enables researchers to identify potential connections and convergence points between distinct disciplines. Such cross-disciplinary perspective plays a pivotal role in facilitating collaborative multidisciplinary research initiatives. Fig. 14 illustrates the co-occurrence relationships among subject categories with a minimum occurrence threshold of 2. Both the visual representation in Fig. 14 and the quantitative data presented in Table 5 demonstrate that PHARMACOLOGY & PHARMACY (341 occurrences) emerges as the most prevalent category, followed sequentially by IMMUNOLOGY (330), RHEUMATOLOGY (242), BIOCHEMISTRY & MOLECULAR BIOLOGY (238), and CELL BIOLOGY (204). The proportional scaling of nodal elements corresponds to frequency metrics, while interconnecting edges represent collaborative linkages. These findings suggest that current research paradigms in this domain maintain foundational scientific inquiry as their core focus, while progressively incorporating multidisciplinary integration to drive diversified development within the field.

| Rank | Subject Categories | Record | Subject Categories | centrality |
| 1 | PHARMACOLOGY & PHARMACY | 341 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 0.43 |
| 2 | IMMUNOLOGY | 330 | CELL BIOLOGY | 0.42 |
| 3 | RHEUMATOLOGY | 242 | IMMUNOLOGY | 0.35 |
| 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | 238 | PHARMACOLOGY & PHARMACY | 0.34 |
| 5 | CELL BIOLOGY | 204 | MEDICINE, RESEARCH & EXPERIMENTAL | 0.16 |
| 6 | CHEMISTRY, MEDICINAL | 146 | MEDICINE, GENERAL & INTERNAL | 0.11 |
| 7 | MEDICINE, RESEARCH & EXPERIMENTAL | 118 | BIOLOGY | 0.11 |
| 8 | INTEGRATIVE & COMPLEMENTARY MEDICINE | 60 | CHEMISTRY, MULTIDISCIPLINARY | 0.1 |
| 9 | MULTIDISCIPLINARY SCIENCES | 55 | ORTHOPEDICS | 0.1 |
| 10 | CHEMISTRY, MULTIDISCIPLINARY | 50 | MICROBIOLOGY | 0.09 |
3.7 Analysis of highly cited references
Highly cited publications serve as vital indicators of academic influence, demonstrating not only research quality but also mapping the foundational knowledge architecture of a field. As shown in Fig. 15, publications with ≥25 citations form a tightly interconnected co-citation network, with the landmark 2009 study published in Arthritis & Rheumatology (the most cited work in this cluster) being particularly prominent. This study focused on evaluating the efficacy and safety profile of VX-702, a p38 MAPK inhibitor, in patients with moderate-to-severe active rheumatoid arthritis (RA). The research employed two 12-week, double-blind, placebo-controlled trials. The authors concluded that the limited clinical benefits and transient anti-inflammatory effects of VX-702 suggest that isolated inhibition of the p38 MAPK pathway may not achieve sustained control of chronic inflammation in RA.17

Fig. 15 demonstrates distinct temporal dynamics of citation bursts across the 2000–2023 period, revealing multiple high-intensity burst publications (sustained for 3–5 years) that signify pivotal shifts in research focus. Notably, these bursts correlate with critical advancements in RA-MAPK research, reflecting evolving disciplinary priorities and sustained scholarly attention to mechanistic breakthroughs.
3.8 Keyword analysis
The keywords were visually analyzed by Vosviewer software, and the frequency of keyword occurrence was set to 1. There were 6078 keywords. Keywords usually reflect the core content and research focus of a paper or article and can be used to quickly locate critical information in related literature, helping researchers to quickly find information related to their research topic in the massive literature database. Through Table 6, Figs. 16 and 17 show the high-frequency keywords and keyword burst, 548 appearing at least five times. The frequency and centrality of the keywords are Nf kappa b (347, 0.04), Activation (231, 0.06), Activated protein kinase (211, 0.08), Gene expression (169, 0.09), Tumor necrosis factor (146, 0.07), Pathway (143, 0.04), necrosis factor alpha (104, 0.06), Map kinase (99, 0.05), Cytokine (89, 0.07), apoptosis (77, 0.04) Map kinase (77, 0.04) Map kinase (75 0.02). Figs. 16 and 17 demonstrate temporal variations in keyword bursts across the 2000–2023 period, highlighting high-intensity emergent terms including signal transduction, NF-κB, c-Jun N-terminal kinase (JNK), and matrix metalloproteinases (MMPs). These sustained bursts (3–5 years duration) reflect evolving research priorities, particularly the mechanistic focus on inflammatory signaling cascades and tissue remodeling pathways in rheumatoid arthritis pathogenesis.
| Rank | Keywords | Record | Keywords | centrality |
| 1 | rheumatoid arthriti | 810 | activated protein kinase | 0.08 |
| 2 | expression | 347 | gene expression | 0.08 |
| 3 | nf kappa b | 326 | tumor necrosis factor | 0.08 |
| 4 | activation | 231 | in vitro | 0.08 |
| 5 | cell | 213 | activation | 0.07 |
| 6 | activated protein kinase | 211 | necrosis factor alpha | 0.06 |
| 7 | gene expression | 169 | rheumatoid arthritis | 0.05 |
| 8 | inflammation | 163 | nf kappa b | 0.05 |
| 9 | tnf alpha | 158 | cell | 0.05 |
| 10 | tumor necrosis factor | 148 | map kinase | 0.05 |


Through keyword trend analysis, the frequency and intensity of keywords varied at different points in time, Fig. 18, from 2001 to 2005, the keywords with higher frequency were factor receptor, gamma production, tissue inhibitor, interleukin-1 receptor antagonist, and biosynthesis. 2005–2010, the keywords mainly include p38, p38 map kinase, activated protein-kinase, tumor necrosis factor, necrosis factor alpha, and n-n-terminal kinase. 2010–2015 keywords mainly include growth factor, synovial fibroblasts, TNF-alpha, T-cells, Nf kappa b, p38 mark, and in vitro. 2015–2020 keywords mainly include mechanisms, expression, inhibition, inflammation, proliferation, fibroblast-like synoviocytes. Keywords for 2020–2023 primarily include classification criteria: pain, hepatocellular carcinoma, medel, autophagy, acid, injury, mask, and so on. Keyword clustering of relevant research literature, case reports, and clinical study data can effectively identify significant themes and trends in the research field, such as new treatments, etiologies, and mechanisms of disease progression. It can help researchers discover the current research hotspots in the field, reveal the crossover and connection between different disciplines, and promote interdisciplinary collaborative research. A total of 9 classes of clustered vocabularies were obtained by clustering the keywords in the field. Figs. 19 and 20 #0 activated protein kinase, #1 expression, #2 nitric oxide, #3 rankl, #4 receptor, #5 p38 map kinase, #6 matrix metalloproteinase, #7 in vivo, # 8in vivo, #9 antiinflammatory drug.



4 Discussion
4.1 Analysis of total article trend
In this study, using the analysis of the WoS core database on the research of RA and MAPK during the period of 2000–2023, the number of articles issued in 2000 was 15, and the number of articles issued in 2005 exceeded 50 for the first time, and after 2005, the number of articles issued continued to increase, basically the number of articles issued per year >50, and the number of articles issued in 2017 exceeded 100 for the first time, meanwhile in 2017, the number of articles issued The total number of articles issued exceeded 1000 for the first time; in general, the number of articles issued in the research field of RA and MAPK showed an increasing trend, indicating that a large number of studies were reported. Analyzed by the trend of total number of articles issued, there are still a large number of articles reported in this field. This indicates that MAPK, as an important pathological process in RA, occupies an important role in the development of the disease.
4.2 Analysis of research hotspots and trends
By analyzing the keywords, the keywords are analyzed according to the time-frequency; firstly, the high-frequency keywords from 2000 to 2005, such keywords include activated protein-kinase, tissue inhibitor, interleukin-1 receptor antagonist, and biosynthesis, and such keywords have some correlation with the clustered keywords. Including #0 activated protein kinase, #1 expression, and #8 protein kinase. c. There are three main classical pathways in the mammalian MAPK family: the P38 pathway, the c-Jun N-terminal kinases (JNK) pathway, and the extracellular signal-regulated kinase (ERK) pathway.18 Different pathways can be activated by various growth factors and cytokines in combination with the corresponding receptors to activate intracellular MAPKKK(MAPkinase kinase kinase), MAPKK(MAPkinase kinase) and MAPK. Different MAPK proteins activate other transcription factors to complete the respective signal transduction.19,20
One study demonstrates that 3′3-Diindolylmethane (DIM), a bioactive compound derived from cruciferous vegetables, exhibits potent anti-proliferative, anti-metastatic, and anti-inflammatory effects on RA-FLSs by inhibiting MAPK and AKT/mTOR signaling pathways. Proliferative, anti-metastatic, and anti-inflammatory effects on RA-FLSs by inhibiting MAPK and AKT/mTOR signaling pathways. DIM effectively suppressed TNF-α-induced upregulation of MMPs and proinflammatory cytokines in vitro and alleviated arthritis severity in AIA mouse models in vivo, suggesting its potential therapeutic effect. Suggesting its potential therapeutic application for rheumatoid arthritis.21 Shen22 et al. found that Corilagin, a component of Geranium Maxim, Corilagin down-regulated overexpression of Bcl-2, IL-6, IL-8, MMP-1, MMP-2, MMP-3, MMP-9, COX-2, and iNOS while up-regulating the level of Bax. In addition, COR decreased the ratios of P-p65/p65, P-IκBα/IκBα, P-ERK/ERK, P-JNK/JNK, and P-p38/p38, and blocked IL-1β-induced nuclear translocation of p65. It also significantly reduced paw swelling and arthritis scores and inhibited synovial tissue proliferation erosion and inflammatory cell infiltration in AIA rats. Also, COR reduced the production of proinflammatory cytokines (IL-6, TNF-α, IL-1β, and IL-17) in serum.
Li et al.23 found that romano and carnosol, two natural phenolic diterpenes from Callicarpalongissima, have anti-rheumatoid arthritis activity. In type II collagen-induced DBA/1 mouse model of arthritis, both romano (40 mg/kg/d) and carnosol (40 mg/kg/d) alone significantly alleviated RA symptoms, including swelling, redness, and synovitis, reduced arthritis index scores, and down-regulated serum proinflammatory cytokines such as interleukin 6 (IL-6), monocyte chemotactic protein 1 (MCP-1) and TNF-αlevels. In addition, both compounds blocked the activation of the Toll-like receptor 4 (TLR4)/nuclear factor κB (NF-κB)/c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) pathways. Of particular note, the anti-RA effect and inhibition of the TLR4/NF-κB/MAPK pathway were significantly enhanced when rosmarinol and rhamnosus acid were used in combination (20 mg/kg/d each).
The following keywords are the keywords from 2005 to 2010; such keywords include p38, p38 map kinase, necrosis factor-alpha, n-terminal kinase activated protein kinase, tumor necrosis factor, signal transduction, and TNF alpha; this type of keywords has some correlation with the clustering keywords, including #3 rankl, #4 receptor, #5 p38 map kinase, and #7 in vivo. The p38 MAPK signaling pathway is significantly activated during the pathogenesis of RA and is involved in joint inflammation and bone destruction by regulating the expression of a series of downstream target genes. Specifically, p38 MAPK can regulate the production and release of inflammatory factors, such as tumor necrosis TNF-α, interleukin-1 (IL-1), and interleukin-6 (IL-6), etc. The P38 pathway serves as one of the critical pathways for the activation of the MAPK pathway, and there are four isoforms of the P38 protein, P38α, P38β, P38γ and P38δ24; Min25 et al. found that IL-25 pretreatment significantly reduced IL-22-induced RANKL expression in FLS of RA, and this inhibition was achieved through STAT3 and p38 MAPK/IκBα signaling pathways. Meanwhile, IL-25 could also reduce osteoclast differentiation and inhibit the expression of osteoclast-related markers, thus inhibiting osteoclastogenesis. Han26 et al. found that Shentong Zhuyu Decoction serum-treated RA-FLS cells showed significant reductions in the OD570 value, migration and invasion abilities, and secretion of IL-1β and MMP-3, while the apoptosis rate was significantly decreased, while the apoptosis rate was significantly increased. Further analyses showed that Shentong Yiyu Tang inhibited the transition of RA-FLS from the G1 phase to the S phase. At the molecular level, Shentong Yiyu Tang significantly inhibited the expression of Bcl-2, CDK4, cyclin D1, phosphorylated MAPK p38 (p-p38), and CTGF, while increasing the levels of Bax, caspase-3, and PPARγ. These effect trends were consistent with those of the MAPK p38 inhibitor (SB203580) and PPARγ agonist (GW1929).
The n-terminal kinase-activated protein kinase mainly refers to c-Jun N-terminal kinase (JNK), which is an essential subclass of the MAPK signaling pathway in mammalian cells, and JNK protein kinase is encoded by three genes (jnk1, jnk2, and jnk3), with The jnk1 and jnk2 genes are widely expressed throughout the body, whereas the jnk3 gene shows restricted expression, mainly in tissues such as brain, heart and testis. In unstimulated cells, JNK is primarily present in the cytoplasm but has some distribution in the nucleus. When cells are stimulated, JNK rapidly and significantly accumulates in the nucleus and phosphorylates specific serine or threonine residues at the amino terminus of its target proteins (e.g., transcription factors such as c-Jun), thus regulating gene expression. In immune response, JNK regulates the proliferation, differentiation, and function of immune cells; JNK also plays a vital role in the development of the nervous system and the repair of injuries.27–30
A study found that activation of ERK, JNK, and p38 MAPK was found almost exclusively in synovial tissue from RA patients, whereas no significant activation was observed in synovial tissue from OA patients. Specifically, ERK activation was mainly localized around synovial microvessels, JNK activation was localized in areas of monocyte infiltration and their interiors, while p38 MAPK activation was observed in the synovial lining layer and synovial endothelial cells. Further studies have shown that TNF-α, IL-1, and IL-6 are the main inducers of ERK, JNK, and p38 MAPK activation in human synoviocytes cultured in vitro.31 Behl32 showed that in a rat model of adjuvant-induced arthritis, synovial tissues showed significantly higher KLF7 KLF7 expression was up-regulated in synovial tissue. Further functional studies revealed that KLF7 deficiency inhibited the proliferation of RA-FLSs and the expression of pro-inflammatory factors (e.g., IL-6, IL-1β, IL-17A) and matrix metalloproteinases (e.g., MMP-1, MMP-3, MMP-13), which was achieved through the inhibition of the phosphorylation of NF-κB p65 and JNK phosphorylation. In addition, it was shown that miR-9a-5p could bind specifically to KLF7, thereby negatively regulating KLF7 expression in RA-FLSs. The present study reveals that KLF7 is involved in the pathogenesis of RA by promoting cell proliferation, pro-inflammatory cytokine release, and MMP expression through activation of the NF-κB and JNK pathways in RA-FLSs.
The following keywords are 2010–2015, including mechanisms, expression, inhibition, inflammation, proliferation, and fibroblast-like synoviocytes. Expression of MAPK Ganoderma lucidum polysaccharide peptide (GLPP) has the ability to effectively alleviate arthritis symptoms and reduce immune organ index, antibody levels, and systemic organ damage in CIA rats. In joint tissues, GLPP decreased the protein expression of TNF-α, IL-1β, IL-6, matrix metalloproteinase (MMP) 2, MMP9, MMP13, BCL-2, osteoblasts, β-connexin and hypoxia-inducible factor (HIF)-1α, while increasing the protein expression of BAX. In addition, GLPP decreased the phosphorylation levels of p65, IκB-α, and ERK1/2.33 In recent years, more and more studies have shown that abnormally expressed long noncoding RNA (lncRNA) can activate multiple signaling pathways, such as MAPK, to regulate the inflammatory response and participate in developing autoimmune diseases.34
Chen et al.35 reported that the expression of lncRNA nuclear paraspeckle assembly transcript 1 (lncRNA NEAT1) in RA synovium was significantly higher than that in normal synovium, whereas the expression of miR-129 and miR-204 was significantly lower, and the phosphorylation of ERK protein was significantly higher in RA synovium, and the proliferation level of FLS was increased. When lncRNA NEAT1 was silenced, ERK protein activation was inhibited, miR-129 and miR-204 expression was up-regulated, and FLS proliferation was reduced.
These results suggest that lncRNA NEAT1 activates the ERK signaling pathway and inhibits miR-129 and miR-204 expression, exacerbating FLS proliferation. Li et al.36 investigated the ‘cross-talk’ between MAPK signaling pathways, and when the JNK inhibitor SP600125 was used to inhibit the JNK protein, the expression of P38 and ERK proteins was inhibited at the same time; and when P38, JNK, and ERK proteins were inhibited, the expression of the inflammatory factors IL-4 and transforming growth factor β1 increased, and the expression of the pro-inflammatory factors interferon γ and IL-17 decreased, and FLS proliferation and inflammatory cell infiltration were significantly reduced.
In addition to the above keywords, which are accidently high-frequency, other keywords, such as #2 nitric oxide, need to be paid attention to. Chondrocyte apoptosis is one of the most important causes of cartilage damage in RA joints. Nitric oxide (NO) and reactive oxygen species (ROS) are the primary inflammatory mediators that cause chondrocyte apoptosis,37 and pro-inflammatory factors such as TNF-α induce the production of these inflammatory mediators through activation of the MAPK signaling pathway, which leads to the activation of apoptotic proteins such as caspases and Fas/Fas-L, resulting in apoptosis. Other apoptotic proteins, such as Fas/Fas/L, resulting in chondrocyte apoptosis.38
Endogenous NO is generally generated from L-arginine catalyzed by inducible NO synthase (iNOS). Inflammatory factors can induce chondrocytes to express high levels of iNOS-catalyzed production of NO. NO induces mitochondrial damage and cystatinase activation, which promotes the formation of apoptotic vesicles and induces apoptosis in chondrocytes. Fibronectin is an essential component of the standard cartilage matrix, and when hydrolyzed to active fibronectin fragments, it can induce chondrocyte apoptosis.39,40 Yasuda et al.41 reported that activation of the P38 signaling pathway by fibronectin fragments up-regulated the expression of iNOS, increasing the NO content. Hyaluronic acid was used to intervene, and it was found that hyaluronic acid inhibited the activation of the P38 signaling pathway by binding to CD44 and intercellular adhesion molecule 1, thereby inhibiting iNOS synthesis, leading to a decrease in NO production and inhibiting chondrocyte apoptosis.
ROS are by-products of aerobic metabolism and are cytotoxic, including superoxide anion radicals, hydroxyl radicals, hydrogen peroxide, and single-linear oxygen nonionic radicals.42,43 Excessive accumulation of ROS in cells causes endoplasmic reticulum stress, which activates the MAPK and other signaling pathways to mediate cystathionine pathway activation and induce apoptosis.44,45 Elevated levels of ROS in RA articular cartilage are the leading cause of increased damage at the joint site, and ROS can exacerbate the secretion of pro-inflammatory factors through activation of the MAPK signaling pathway, leading to joint damage. Dinucleotide phosphatase oxidase 4 (NOX4), P38 protein expression level, and ROS level were significantly increased after dexamethasone treatment. Inhibition with the NOX inhibitor apocynin and the P38 inhibitor SB203580 decreased P38, cystatinase 3, and NOX4 protein expression and ROS levels.46 This suggests that acetosyringone and SB203580 can inhibit the phosphorylation of the P38 signaling pathway, down-regulate cystatinase expression, inhibit the increase in ROS levels caused by NOX4, and inhibit chondrocyte apoptosis. Lee et al.47 proposed a novel stimuli-responsive and tolerogenic dendritic cell-derived exosome (TolDex) for the treatment of RA that can target RA with the help of a novel stimuli-responsive and TolDex. This exosome is capable of targeting RA lesions for specific immunomodulation. By introducing polyethylene glycol (PEG) containing a thioketone (TK) linker on the surface of TolDex, it is enabled to respond to ROS stimulation in the RA microenvironment. When ROS are overproduced, the PEG chains are shed, promoting the uptake of ROS-responsive TolDex (TKDex) by activated immune cells. TKDex was shown to down-regulate CD40 expression on mature dendritic cells (mDCs) and regulate the secretion of pro-inflammatory cytokines, including TNF-α and IL-6. In a mouse model of collagen-induced arthritis (CIA), TKDex prolonged its circulation time in the bloodstream and enhanced its accumulation in the joints after PEG was injected intravenously. Meanwhile, TKDex decreased IL-6 levels, increased transforming growth factor-β (TGF-β) levels, and induced CD4+CD25+Foxp3+ regulatory T cells in CIA mice.
Ma et al.48 suggested that pro-inflammatory M1-type macrophages with high expression of ROS and NO induce synovial inflammation and bone erosion during the development of RA. Eliminating ROS and NO in inflamed joints is a potential therapeutic approach for RA that promotes the transition of pro-inflammatory M1-type macrophages to anti-inflammatory M2-type. In this study, we exploited DNA molecules' inherent ROS and NO scavenging ability to develop folic acid-modified triangular DNA origami nanostructures (FA-tDONs) for targeted RA therapy. The FA-tDONs efficiently scavenged ROS and NO and actively targeted M1-type macrophages to promote the transition from M1-type to M2-type, restoring relevant cytokines and biomarkers to average levels.
The destruction of the articular cartilage matrix is mainly caused by ECM hyperhidrosis and chondrocyte apoptosis due to the overproduction of MMP mediated by the MAPK signaling pathway, a family of ion-dependent zinc-containing endopeptidases capable of hydrolyzing the main components of the ECM, such as collagen, elastin and proteoglycan.49 Chondrocytes are the only cellular component of articular cartilage and have limited proliferative capacity, and after apoptosis, there are no monocytes in the articular cartilage to decompose the residue, which accumulates and causes damage to other components of the matrix.50
MMP is usually present as zymogen in ECM and can be synthesized and secreted by FLS and chondrocytes in response to epidermal growth factor, transforming growth factor, IL-1, IL-4, IL-5, IL-6, IL-8, IL-10, and macrophage colony-stimulating factor, etc. MMP-1 belongs to the class of collagen-degrading enzymes that hydrolyze collagen types I, II, and III in ECM and is an essential protease in the degradation of RA and chondrocytes.51–53 Ma54 et al. found that artesunate significantly inhibited the migration and invasive capacity of RA-FLS in a dose-dependent manner, and this effect was present in the presence or absence of TNF-α stimulation. Artesunate mediated its inhibitory effect by inhibiting the production of MMP-2 and MMP-9, and exogenous MMP-9 was able to reverse the inhibitory effect of artesunate on RA-FLS invasion. Compared with hydroxychloroquine, artesunate had a more substantial inhibitory effect on RA-FLS migration and invasion and a better anti-inflammatory effect. The inhibitory effects of artesunate and methotrexate were similar, and they showed synergistic effects when used in combination. Mechanistically, artesunate significantly inhibited PDK-1 expression and phosphorylation of Akt and RSK2, identical to the effects of the PDK-1-specific inhibitors AR-12 or PDK-1 knockdown. This inhibition led to a reduction in RA-FLS migration and invasion as well as a decrease in MMP-2 and MMP-9 expression. Another study found that quercetin significantly reduced RA FLS migration, invasive capacity, and MMP expression and inhibited the reorganization of the actin backbone during cell migration. Using collagen-induced arthritis (CIA) mice as a model, the results showed that quercetin significantly reduced the severity of arthritis in CIA mice. Further mechanistic studies revealed that quercetin was able to inhibit tumor necrosis factor (TNF)-α-induced activation of the MAPK pathway without affecting TNF-α receptor expression.55
RA, as a complex and intractable chronic autoimmune disease, has long been a focus of medical attention. In the course of its development, the disease not only leads to significant destruction of joint structures, but in severe cases, it may also affect distal organs such as the lungs and heart, resulting in multi-system involvement. For the prevention and treatment strategy of RA, current research focuses on several key aspects, including inhibiting the abnormal proliferation of FLS, counteracting the over-infiltration of inflammatory cells, and preventing the formation of neovascularisation and vascular opacification, which are essential for slowing down the progression of the disease.
At the level of molecular mechanisms, the MAPK signaling pathway plays a central role in the pathophysiology of RA as a key pathway regulating eukaryotic cell proliferation, differentiation, and function. Studies have shown that activated MAPK protein triggers two major chains of pathological effects by precisely regulating the activity of downstream transcription factors: first, it directly promotes the abnormal proliferation of synoviocytes and programmed death of chondrocytes, which exacerbates local tissue damage in the joints; and second, it induces overexpression of members of the MMPs family of enzymes in synoviocytes and chondrocytes that are capable of over-hydrolyzing ECM, thereby disrupting the structural integrity of the joint and ultimately leading to loss of joint function.
It is worth noting that the MAPK signaling pathway has an intricate regulatory mechanism, which functions independently and interacts closely with other key signaling pathways, such as Akt and NF-κB, to weave a sophisticated regulatory network. The synergistic and antagonistic interactions between these multiple pathways make the pathogenesis of RA more complex and varied and pose a great challenge to the development of specific and efficient RA therapeutic drugs.
Therefore, an in-depth investigation of the interactions between MAPK and other signaling pathways in RA and revealing their specific modes of action during disease development is of great significance in guiding the design and development of novel RA therapeutic drugs.
While this study provides a systematic bibliometric exploration, certain methodological limitations inherent to our analytical framework warrant acknowledgment. Compared to prior investigations in the field.56–59, constraints persist in data source comprehensiveness (restricted to WoS Core Collection) and temporal granularity of trend analyses. Future iterations will incorporate multidimensional validation through.
4.3 Limitations of this study
Several limitations were encountered during the literature review phase of this study. Firstly, the data collection was limited to the Web of Science database, which may need to be revised to comprehensively cover the broad field of research related to RA and MAPK signaling pathway, and therefore, potentially significant research results were missed. In order to compensate for this deficiency, future studies should broaden the horizon by including mainstream academic databases, such as Scopus and Google Scholar, to obtain a more comprehensive and diversified research perspective.
In addition, this study focused on the analysis of journal articles but needed to consider diverse forms of academic output such as review articles, book chapters, conference papers, etc., which weakened the completeness of the study to a certain extent. To enhance the depth and breadth of the study, future explorations should adopt a comprehensive cross-database analysis method and incorporate advanced search strategies to ensure the comprehensiveness and accuracy of information retrieval.
To further enhance the reliability and depth of the study, it is recommended to combine qualitative research methods with factual research and in-depth interviews to directly obtain first-hand information from experts and patients in the field of RA and MAPK signaling pathways. This method not only can deeply analyze the current status and bottlenecks of current research but also can provide more targeted and scientific strategic recommendations based on empirical data.
In conclusion, despite the limitations of this study, it lays a solid foundation for the subsequent exploration of RA and MAPK signaling pathways and reveals the tremendous research potential in this field. Future studies should explore related issues, including traumatic optic neuropathy, more comprehensively by expanding database coverage, optimizing search strategies, and incorporating qualitative research methods, thereby contributing to accumulating knowledge and scientific progress in this field. The results and methodology of this study provide a valuable reference framework for peers, which can help promote more systematic and in-depth academic research and jointly move towards more comprehensive and reliable scientific conclusions.
Guardian/patient's consent
Not applicable.
Ethical statement
Not applicable.
Credit author statement
Formal analysis: Jian Gao.
Methodology: Jian Gao.
Software: Jing Xu.
Supervision: Jing Xu.
Validation: Hui Li.
Visualization: Chong Gao.
Writing – original draft: Chong Gao, Jian Gao.
Writing – review & editing: Jian Gao, Chong Gao.
Funding statement
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Funding was provided by the Xinjiang Uygur Natural Science Foundation (TSYC202301B107) and Xinjiang Uygur Natural Science Fund (2022D01C583); the Lianyungang Science and Technology Bureau Basic Research Program (General Program), number JCYJ2431; the Lianyungang Health Science and Technology Project for Young Doctors, number QN202416; and the Educational Research Project of Kangda College, Nanjing Medical University, number KD2025JYYJYB010.
References
- Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases. Ann Rheum Dis August 6, 2024
- [Google Scholar]
- Harnessing the power of stimuli-responsive nanoparticles as an effective therapeutic drug delivery system. Adv Mater. 2024;36(24)
- [Google Scholar]
- The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021;41(5):863-877.
- [Google Scholar]
- Melatonin regulates rheumatoid synovial fibroblasts-related inflammation: implications for pathological skeletal muscle treatment. J Pineal Res. 2024;76(6)
- [Google Scholar]
- Bidirectional Mendelian randomization explores the causal relationship between dietary habits and rheumatoid arthritis. Medicine (Baltim). 2024;103(38)
- [Google Scholar]
- Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis. Drugs. 2013;73(2):101-115.
- [Google Scholar]
- Discovery of novel small molecule dual inhibitor targeting toll-like receptors 7 and 9. J Chem Inf Model. 2024;64(13):5090-5107.
- [Google Scholar]
- Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases. Biochem Pharmacol. 2024;220
- [Google Scholar]
- Global research progress of electroencephalography applications in attention deficit hyperactivity disorder: bibliometrics and visualized analysis. Medicine (Baltim). 2024;103(38)
- [Google Scholar]
- Critical care in older adults: research landscape and hotspots from a bibliometric perspective. Medicine (Baltim). 2024;103(38)
- [Google Scholar]
- A bibliometric analysis of domestic and international research on hemorrhagic fever with renal syndrome over the past 2 decades. Medicine (Baltim). 2024;103(37)
- [Google Scholar]
- Intersecting evidence: bibliometric analysis and clinical trials illuminate immunotherapy in KRAS-mutation cancer: a review. Medicine (Baltim). 2024;103(36)
- [Google Scholar]
- Emerging trends and hotspots in peptic ulcer from 2008 to 2023: a bibliometric analysis. Medicine (Baltim). 2024;103(36)
- [Google Scholar]
- Spotlight on endoplasmic reticulum stress in acute kidney injury: a bibliometric analysis and visualization from 1997 to 2024. Medicine (Baltim). 2024;103(36)
- [Google Scholar]
- Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies. Arthritis Rheum. 2009;60(5):1232-1241.
- [Google Scholar]
- Another notch in the belt of rheumatoid arthritis. Arthritis Rheumatol. 2024;76(10):1475-1487.
- [Google Scholar]
- Novel trifluoromethyl ketone derivatives as oral cPLA2/COX-2 dual inhibitors for resolution of inflammation in rheumatoid arthritis. Bioorg Chem. 2024;148
- [Google Scholar]
- MAPK-activated protein kinases: servant or partner? Annu Rev Biochem. 2022;91:505-540.
- [Google Scholar]
- A novel phytochemical, DIM, inhibits proliferation, migration, invasion and TNF-α induced inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients by targeting MAPK and AKT/mTOR signal pathway. Front Immunol. 2019;10:1620.
- [Google Scholar]
- Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating NF-κB and MAPK signaling pathways. J Ethnopharmacol. 2022;284
- [Google Scholar]
- Rosmanol and carnosol synergistically alleviate rheumatoid arthritis through inhibiting TLR4/NF-κB/MAPK pathway. Molecules. 2021;27(1):78.
- [Google Scholar]
- Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway. Arthritis Res Ther. 2020;22(1):222.
- [Google Scholar]
- Shentong Zhuyu decoction inhibits inflammatory response, migration, and invasion and promotes apoptosis of rheumatoid arthritis fibroblast-like synoviocytes via the MAPK p38/PPARγ/CTGF pathway. BioMed Res Int. 2021;2021
- [Google Scholar]
- Activation of c-Jun N-Terminal kinase, a potential therapeutic target in autoimmune arthritis. Cells. 2020;9(11):2466.
- [Google Scholar]
- Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911-1912.
- [Google Scholar]
- Novel c-Jun N-Terminal kinase (JNK) inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one scaffold. Molecules. 2021;26(18):5688.
- [Google Scholar]
- Exploring the role of polyphenols in rheumatoid arthritis. Crit Rev Food Sci Nutr. 2022;62(19):5372-5393.
- [Google Scholar]
- From death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: the receptor-interacting protein 1 odyssey [published correction appears in immunol rev. 2008 Feb;221:229] Immunol Rev. 2007;220:8-21.
- [Google Scholar]
- Inhibition of Kruppel-like factor 7 attenuates cell proliferation and inflammation of fibroblast-like synoviocytes in rheumatoid arthritis through nuclear factor κB and mitogen-activated protein kinase signaling pathway. Exp Anim. 2022;71(3):356-367.
- [Google Scholar]
- Exploring the role of polyphenols in rheumatoid arthritis. Crit Rev Food Sci Nutr. 2022;62(19):5372-5393.
- [Google Scholar]
- Ganoderma lucidum polysaccharide peptide (GLPP) attenuates rheumatic arthritis in rats through inactivating NF-κB and MAPK signaling pathways. Phytomedicine. 2023;119
- [Google Scholar]
- Noncoding RNAs: master regulators of inflammatory signaling. Trends Mol Med. 2018;24(1):66-84.
- [Google Scholar]
- Silencing long non-coding RNA NEAT1 attenuates rheumatoid arthritis via the MAPK/ERK signalling pathway by downregulating microRNA-129 and microRNA-204. RNA Biol. 2021;18(5):657-668.
- [Google Scholar]
- Immunosuppressive effect of geniposide on mitogen-activated protein kinase signalling pathway and their cross-talk in fibroblast-like synoviocytes of adjuvant arthritis rats. Molecules. 2018;23(1):91.
- [Google Scholar]
- Nitric oxide scavenging and hydrogen sulfide production synergistically treat rheumatoid arthritis. Adv Healthcare Mater. 2023;12(4)
- [Google Scholar]
- Exhaled nitric oxide in early rheumatoid arthritis and effects of methotrexate treatment. Sci Rep. 2022;12(1):6489.
- [Google Scholar]
- N-Acetyl-L-cysteine in human rheumatoid arthritis and its effects on nitric oxide (NO) and malondialdehyde (MDA): analytical and clinical considerations. Amino Acids. 2022;54(9):1251-1260.
- [Google Scholar]
- Nitric oxide-scavenging nanogel for treating rheumatoid arthritis. Nano Lett. 2019;19(10):6716-6724.
- [Google Scholar]
- Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1. Mediat Inflamm. 2013;2013
- [Google Scholar]
- Rheumatoid arthritis synovial fluid neutrophils drive inflammation through production of chemokines, reactive oxygen species, and neutrophil extracellular traps. Front Immunol. 2021;11
- [Google Scholar]
- Ferroptosis in rheumatoid arthritis: a potential therapeutic strategy. Front Immunol. 2022;13
- [Google Scholar]
- Methotrexate mechanism in treatment of rheumatoid arthritis. Jt Bone Spine. 2019;86(3):301-307.
- [Google Scholar]
- Rheumatoid arthritis and oxidative stress. Cell Mol Biol (Noisy-le-grand). 2022;68(6):174-184.
- [Google Scholar]
- Glucocorticoids induce apoptosis and matrix metalloproteinase-13 expression in chondrocytes through the NOX4/ROS/p38 MAPK pathway. J Steroid Biochem Mol Biol. 2018;181:52-62.
- [Google Scholar]
- Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis. Acta Biomater. 2021;128:462-473.
- [Google Scholar]
- DNA Origami as a nanomedicine for targeted rheumatoid arthritis therapy through reactive oxygen species and nitric oxide scavenging. ACS Nano. 2022;16(8):12520-12531.
- [Google Scholar]
- A comprehensive analysis of biomarkers associated with synovitis and chondrocyte apoptosis in osteoarthritis. Front Immunol. 2023;14
- [Google Scholar]
- The role of apoptosis in the pathogenesis of osteoarthritis. Int Orthop. 2023;47(8):1895-1919.
- [Google Scholar]
- STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κB signaling pathway. Cell Death Dis. 2021;12(1):13.
- [Google Scholar]
- MTORC1 coordinates the autophagy and apoptosis signaling in articular chondrocytes in osteoarthritic temporomandibular joint. Autophagy. 2020;16(2):271-288.
- [Google Scholar]
- Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Phys. 1998;110(1):65-72.
- [Google Scholar]
- A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Res Ther. 2019;21(1):153.
- [Google Scholar]
- Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway. Int Immunopharmacol. 2018;55:174-182.
- [Google Scholar]
- Bibliometric and visualization analysis of research hotspots and frontiers in endoscopic lumbar discectomy. J Pain Res. 2024;17:2165-2190.
- [Google Scholar]
- Hotspot analysis and frontier exploration of stem cell research in intervertebral disc regeneration and repair: a bibliometric and visualization study. World Neurosurg. 2024;184:e613-e632.
- [Google Scholar]
- Bibliometric and visualization analysis of biomechanical research on lumbar intervertebral disc. J Pain Res. 2023;16:3441-3462.
- [Google Scholar]
- Global research hotspots and frontiers of myasthenia gravis from 2002 to 2021: a bibliometric study. Medicine (Baltim). 2023;102(24)
- [Google Scholar]
